Pacific Biosciences Of California Operating Income 2010-2024 | PACB
Pacific Biosciences Of California operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Pacific Biosciences Of California Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-334 |
| 2022 | $-307 |
| 2021 | $-210 |
| 2020 | $-104 |
| 2019 | $-101 |
| 2018 | $-101 |
| 2017 | $-90 |
| 2016 | $-71 |
| 2015 | $-29 |
| 2014 | $-63 |
| 2013 | $-78 |
| 2012 | $-94 |
| 2011 | $-110 |
| 2010 | $-140 |
| 2009 | $-88 |
| Pacific Biosciences Of California Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-64 |
| 2024-06-30 | $-176 |
| 2024-03-31 | $-81 |
| 2023-12-31 | $-88 |
| 2023-09-30 | $-82 |
| 2023-06-30 | $-73 |
| 2023-03-31 | $-91 |
| 2022-12-31 | $-87 |
| 2022-09-30 | $-75 |
| 2022-06-30 | $-68 |
| 2022-03-31 | $-78 |
| 2021-12-31 | $-65 |
| 2021-09-30 | $-74 |
| 2021-06-30 | $-38 |
| 2021-03-31 | $-34 |
| 2020-12-31 | $-24 |
| 2020-09-30 | $-24 |
| 2020-06-30 | $-24 |
| 2020-03-31 | $-33 |
| 2019-12-31 | $-18 |
| 2019-09-30 | $-28 |
| 2019-06-30 | $-24 |
| 2019-03-31 | $-30 |
| 2018-12-31 | $-31 |
| 2018-09-30 | $-25 |
| 2018-06-30 | $-22 |
| 2018-03-31 | $-24 |
| 2017-12-31 | $-21 |
| 2017-09-30 | $-22 |
| 2017-06-30 | $-24 |
| 2017-03-31 | $-23 |
| 2016-12-31 | $-18 |
| 2016-09-30 | $-17 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-19 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $3 |
| 2015-06-30 | $-11 |
| 2015-03-31 | $-19 |
| 2014-12-31 | $-18 |
| 2014-09-30 | $-8 |
| 2014-06-30 | $-18 |
| 2014-03-31 | $-18 |
| 2013-12-31 | $-17 |
| 2013-09-30 | $-20 |
| 2013-06-30 | $-20 |
| 2013-03-31 | $-21 |
| 2012-12-31 | $-22 |
| 2012-09-30 | $-23 |
| 2012-06-30 | $-23 |
| 2012-03-31 | $-28 |
| 2011-12-31 | $-23 |
| 2011-09-30 | $-29 |
| 2011-06-30 | $-23 |
| 2011-03-31 | $-35 |
| 2010-12-31 | $-37 |
| 2010-09-30 | $-41 |
| 2010-06-30 | $-33 |
| 2010-03-31 | $-30 |
| 2009-12-31 | |
| 2009-09-30 | $-25 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.641B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.963B | 25.00 |
| Intuitive Surgical (ISRG) | United States | $191.657B | 100.20 |
| Edwards Lifesciences (EW) | United States | $43.285B | 27.49 |
| Alcon (ALC) | Switzerland | $42.325B | 28.32 |
| IQVIA Holdings (IQV) | United States | $36.881B | 20.32 |
| IDEXX Laboratories (IDXX) | United States | $36.416B | 42.88 |
| DexCom (DXCM) | United States | $31.017B | 46.71 |
| Waters (WAT) | United States | $23.177B | 34.27 |
| STERIS (STE) | Ireland | $21.145B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.889B | 0.00 |
| Hologic (HOLX) | United States | $17.436B | 18.83 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.025B | 14.40 |
| Sysmex ADR (SSMXY) | Japan | $12.739B | 39.95 |
| Globus Medical (GMED) | United States | $11.287B | 28.58 |
| Masimo (MASI) | United States | $9.351B | 45.25 |
| Penumbra (PEN) | United States | $9.298B | 91.08 |
| Teleflex (TFX) | United States | $8.663B | 13.82 |
| Glaukos (GKOS) | United States | $7.520B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.758B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.684B | 26.55 |
| Veracyte (VCYT) | United States | $3.331B | 99.95 |
| Inari Medical (NARI) | United States | $3.223B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.717B | 15.69 |
| Nihon Kohden (NHNKY) | Japan | $2.514B | 19.10 |
| TransMedics (TMDX) | United States | $2.315B | 73.39 |
| Elekta AB (EKTAY) | Sweden | $2.239B | 20.13 |
| Tandem Diabetes Care (TNDM) | United States | $2.221B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.853B | 9.68 |
| RxSight (RXST) | United States | $1.579B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.369B | 0.00 |
| Artivion (AORT) | United States | $1.250B | 82.86 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.025B | 0.00 |
| Paragon 28 (FNA) | United States | $0.879B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.709B | 0.00 |
| IRadimed (IRMD) | United States | $0.701B | 37.88 |
| Mesa Laboratories (MLAB) | United States | $0.700B | 16.50 |
| AxoGen (AXGN) | United States | $0.653B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.496B | 29.18 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.460B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.449B | 24.29 |
| Delcath Systems (DCTH) | United States | $0.373B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.231B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.212B | 0.00 |
| Accuray (ARAY) | United States | $0.208B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.159B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.145B | 15.56 |
| Spectral Diagnostics (EDTXF) | Canada | $0.106B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.093B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.092B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.084B | 0.00 |
| InspireMD (NSPR) | Israel | $0.082B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.035B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |